MD4282C1 - Use of polyoxometalate complexes with central selenium atoms as compounds possessing antitumor activity - Google Patents

Use of polyoxometalate complexes with central selenium atoms as compounds possessing antitumor activity

Info

Publication number
MD4282C1
MD4282C1 MDA20130003A MD20130003A MD4282C1 MD 4282 C1 MD4282 C1 MD 4282C1 MD A20130003 A MDA20130003 A MD A20130003A MD 20130003 A MD20130003 A MD 20130003A MD 4282 C1 MD4282 C1 MD 4282C1
Authority
MD
Moldova
Prior art keywords
antitumor activity
central
compounds possessing
selenium atoms
possessing antitumor
Prior art date
Application number
MDA20130003A
Other languages
Moldavian (mo)
Romanian (ro)
Russian (ru)
Other versions
MD4282B1 (en
Inventor
Татьяна ГУЦУЛ
Анатол ДИМОГЛО
Петр ПЕТРЕНКО
Севал КОРКМАЗ
Татьяна МИРОНИК
Original Assignee
ИНСТИТУТ ЭЛЕКТРОННОЙ ИНЖЕНЕРИИ И НАНОТЕХНОЛОГИЙ "D. Ghitu" АНМ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ИНСТИТУТ ЭЛЕКТРОННОЙ ИНЖЕНЕРИИ И НАНОТЕХНОЛОГИЙ "D. Ghitu" АНМ filed Critical ИНСТИТУТ ЭЛЕКТРОННОЙ ИНЖЕНЕРИИ И НАНОТЕХНОЛОГИЙ "D. Ghitu" АНМ
Priority to MDA20130003A priority Critical patent/MD4282C1/en
Publication of MD4282B1 publication Critical patent/MD4282B1/en
Publication of MD4282C1 publication Critical patent/MD4282C1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to medicine, namely to the use of polyoxometalate complexes as compounds possessing antitumor activity.According to the invention, the use of polyoxometalate complexes with central selenium atoms of formula Na7[Cu3Na3(H2O)9(SeW9O33)2]·nH2O, where n = 11,5; 13; 23, is claimed, as compounds possessing antitumor activity.
MDA20130003A 2012-12-11 2012-12-11 Use of polyoxometalate complexes with central selenium atoms as compounds possessing antitumor activity MD4282C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20130003A MD4282C1 (en) 2012-12-11 2012-12-11 Use of polyoxometalate complexes with central selenium atoms as compounds possessing antitumor activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20130003A MD4282C1 (en) 2012-12-11 2012-12-11 Use of polyoxometalate complexes with central selenium atoms as compounds possessing antitumor activity

Publications (2)

Publication Number Publication Date
MD4282B1 MD4282B1 (en) 2014-04-30
MD4282C1 true MD4282C1 (en) 2014-11-30

Family

ID=50685409

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20130003A MD4282C1 (en) 2012-12-11 2012-12-11 Use of polyoxometalate complexes with central selenium atoms as compounds possessing antitumor activity

Country Status (1)

Country Link
MD (1) MD4282C1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105859820A (en) * 2016-03-31 2016-08-17 中北大学 Folic acid-coated dehydrocholic acid-polyxomolybdates-pyrene hybrid and preparation method thereof

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62230619A (en) * 1986-03-31 1987-10-09 Poritoronikusu:Kk Alkali salt of heteropolyacid ion
JPH01249725A (en) * 1988-03-30 1989-10-05 Terumo Corp Antitumor agent
JPH0283328A (en) * 1988-09-20 1990-03-23 Terumo Corp Antitumor agent
JPH02204416A (en) * 1989-02-03 1990-08-14 Terumo Corp Antitumor agent
JPH02204415A (en) * 1989-02-03 1990-08-14 Terumo Corp Antitumor agent
CN1258506A (en) * 1998-12-29 2000-07-05 东北师范大学 Nonatungsten trititanium silicate used as antitumor drug
US6656509B1 (en) * 1998-06-09 2003-12-02 Biosyn Arzneimittel Gmbh Combination of selenium-containing compounds with cytostatics
CN1523018A (en) * 2003-09-09 2004-08-25 东北师范大学 Heteropolyacid 5-fluorouracil antineoplastic and method for synthesizing the same
MD4014B1 (en) * 2009-04-23 2010-02-26 Tatiana Gutul Polyoxometalate complexes with antitumor activity
US20100172822A1 (en) * 2007-06-13 2010-07-08 University Of Science And Technology Of China Use of sodium selenosulfate for supplementing selenium and enhancing the therapeutic efficacy of chemotherapy agents, and a rapid process for preparing sodium selenosulfate

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62230619A (en) * 1986-03-31 1987-10-09 Poritoronikusu:Kk Alkali salt of heteropolyacid ion
JPH01249725A (en) * 1988-03-30 1989-10-05 Terumo Corp Antitumor agent
JPH0283328A (en) * 1988-09-20 1990-03-23 Terumo Corp Antitumor agent
JPH02204416A (en) * 1989-02-03 1990-08-14 Terumo Corp Antitumor agent
JPH02204415A (en) * 1989-02-03 1990-08-14 Terumo Corp Antitumor agent
US6656509B1 (en) * 1998-06-09 2003-12-02 Biosyn Arzneimittel Gmbh Combination of selenium-containing compounds with cytostatics
CN1258506A (en) * 1998-12-29 2000-07-05 东北师范大学 Nonatungsten trititanium silicate used as antitumor drug
CN1523018A (en) * 2003-09-09 2004-08-25 东北师范大学 Heteropolyacid 5-fluorouracil antineoplastic and method for synthesizing the same
US20100172822A1 (en) * 2007-06-13 2010-07-08 University Of Science And Technology Of China Use of sodium selenosulfate for supplementing selenium and enhancing the therapeutic efficacy of chemotherapy agents, and a rapid process for preparing sodium selenosulfate
MD4014B1 (en) * 2009-04-23 2010-02-26 Tatiana Gutul Polyoxometalate complexes with antitumor activity

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105859820A (en) * 2016-03-31 2016-08-17 中北大学 Folic acid-coated dehydrocholic acid-polyxomolybdates-pyrene hybrid and preparation method thereof

Also Published As

Publication number Publication date
MD4282B1 (en) 2014-04-30

Similar Documents

Publication Publication Date Title
MX2015010125A (en) Pyridazinone-amides derivatives.
PH12017500755A1 (en) 2 substituted cephem compounds
PH12016500225B1 (en) Novel quinoline-substituted compound
PH12015501576A1 (en) Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
EP4335507A3 (en) Combination therapy
AU2014270524A8 (en) 2-phenylimidazo [1,2-a]pyrimidines as imaging agents
MX2015010128A (en) Macrocyclic pyridazinone derivatives.
MX2014013858A (en) Method for treating a gd2 positive cancer.
MX2019009100A (en) Novel triazolo[4,5-d]pyrimidine derivatives.
PH12014502496B1 (en) Bicyclically substituted uracils and the use thereof
NZ705313A (en) Novel 4,6-disubstituted aminopyrimidine derivatives
MX353363B (en) The use of aryl or heteroaryl substituted dithiolene metal complexes as ir absorbers.
MD4282C1 (en) Use of polyoxometalate complexes with central selenium atoms as compounds possessing antitumor activity
MX2016006807A (en) Imidazole derivatives.
TN2015000095A1 (en) Macrolide derivatives, preparation thereof and therapeutic use thereof
EA033160B1 (en) Compounds for the treatment of ischemia-reperfusion- related diseases
PH12015502703A1 (en) Pharmaceutical compositions
PH12015500262A1 (en) Novel pyridine derivatives
AU2014269144A8 (en) Bioactive compounds
IN2013DE03665A (en)
MD4291B1 (en) Medicinal preparation for the treatment of otitis
MX371037B (en) Oxazolidinone-quinolone hybrid antibacterials for the parenteral treatment or prophylaxis of bacterial diseases.
UA89447U (en) Compound 1,1-diethylcarboxy-2-chloro- 2-trifluoromethylethylene with potential physiological properties
UA71797U (en) Derivatives of 1,2,4-triazole stimulating egg productivity of quails
NZ628565A (en) New pediatric uses of cabazitaxel

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees